While several biomarkers—such as PDSS2, GRSF1, and SLC39A8—have been reported to predict prognosis in CRC (35–37), these markers are often evaluated in isolation, limiting their predictive power. The gene discussed is PDSS2; the disease is colorectal carcinoma.